SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
The medical condition or reason for a Sexual Health and HIV Episode.
Description
The medical condition or reason for a Sexual Health and HIV Episode.
National Codes
| Code | Description |
|---|---|
| A1 | Primary syphilis |
| A2 | Secondary syphilis |
| A3 | Early latent syphilis |
| A4 | Cardiovascular syphilis |
| A5 | Neurosyphilis |
| A6 | All other late and latent syphilis |
| A7A | Congenital syphilis |
| A10 | Ocular syphilis |
| A11 | Otosyphilis |
| B | Gonorrhoea |
| C1 | Chancroid |
| C2 | Lymphogranuloma venereum (LGV) |
| C3 | Donovanosis |
| C4 | Chlamydial infection |
| C4N | Non-specific genital infection (NSGI) |
| C5A | Pelvic inflammatory disease (PID) and epididymitis |
| C5B | Ophthalmia neonatorum |
| C6A | Trichomoniasis |
| C6B | Anaerobic/Bacterial vaginosis and anaerobic balanitis |
| C6C | Other vaginosis/vaginitis/balanitis |
| C7A | Anogenital candidosis |
| C8 | Scabies |
| C9 | Pediculosis pubis |
| C10A | Anogenital Herpes simplex: First episode |
| C10B | Anogenital Herpes simplex: Recurrent episode |
| C11A | Anogenital warts infection: First episode |
| C11D | Anogenital warts infection: Recurrent episode |
| C12 | Molluscum contagiosum |
| C13 | Viral hepatitis B (HbsAg positive): First diagnosis |
| C14 | Viral hepatitis C: First diagnosis |
| C15 | Viral hepatitis A: Acute infection |
| C16 | Mycoplasma genitalium |
| D2A | Urinary Tract Infection |
| D2B |
Other conditions requiring treatment at Level 3 Genitourinary Medicine Services |
| H | HIV positive - Previously Diagnosed |
| H1 | New HIV diagnosis |
| H1A | New HIV diagnosis: Acute |
| H1B | New HIV diagnosis: Late infection (AIDS defined) |
| H2 | Attendance for HIV-related care |
| P4A | Cervical cytology: minor abnormality |
| P4B | Cervical cytology: major abnormality |
| T1 | Chlamydia test |
| T2 | Chlamydia and gonorrhoea tests |
| T3 | Chlamydia, gonorrhoea and syphilis tests |
| T4 | Chlamydia, gonnorrhoea, syphilis and HIV antibody tests |
| T5 | Herpes Simplex Virus (HSV) Test |
| T6 | Hepatitis A/B/C Test |
| TS | Microscopy |
| TT | 3 Site Testing (chlamydia and gonorrhoea) |
| T7 | Syphilis and HIV Testing |
| T8 | Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation |
| T9 | STI testing not required/appropriate |
| T10 | Rapid testing (STI and/or HIV) |
| T11 | Chlamydia test declined |
| T12 | Mycoplasma genitalium test |
| O20 | Hepatitis A vaccination: 1st dose |
| O21 | Hepatitis A vaccination: Subsequent dose |
| O22 | Hepatitis A immune |
| O23 | Partner notification related attendance: Hepatitis A contact |
| O31 | PrEP eligibility criteria 1: MSM/transgender woman |
| O32 | PrEP eligibility criteria 2: HIV positive partner |
| O33 | PrEP eligibility criteria 3: Other high risk |
| O41 | PrEP regimen: Starting or continuing daily Prep |
| O42 | PrEP regimen: Starting or continuing event based Prep |
| O43 | PrEP regimen: Continued through other source |
| O44 | PrEP regimen: Offered and declined |
| O45 | PrEP regimen: Stopped |
| O51 | PrEP prescription: 30 tablets |
| O52 | PrEP prescription: 60 tablets |
| O53 | PrEP prescription: 90 tablets |
| O60 | PrEP patient characteristic: Transgender |
| P1A | Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen) |
| P1B | Human Immunodeficiency Virus (HIV) antibody test offered and refused |
| P1C | HIV test inappropriate |
| P2A | Hepatitis B vaccination: 1st dose |
| P2B | Hepatitis B vaccination: 2nd dose |
| P2C | Hepatitis B vaccination: 3rd dose |
| P2D | Hepatitis B vaccination: 4th dose |
| P2E | Hepatitis B vaccination: Booster |
| P2I | Hepatitis B immune |
| P3 |
CONTRACEPTION
and family planning advice (excluding condom provision) |
| P4 | Cervical cytology done |
| REF1 |
Referral from Chlamydia Screening Programme |
| REF2 |
Referral to a Level 3 Genitourinary Medicine Service |
| REF3 | Referral from home testing/sampling service |
| SG1 | Shigella flexneri (group B) |
| SG2 | Shigella sonnei (group D) |
| SG3 | Shigella other/unspecified |
| SRH |
Sexual and Reproductive Health PATIENT |
| W1 | HPV vaccination: 1st dose |
| W2 | HPV vaccination: 2nd dose |
| W3 | HPV vaccination: 3rd dose |
| W4 | HPV vaccination: offered and declined |
| W5 | HPV vaccination: previously received in full |
| PN | Partner notification initiated related attendance |
| PNC | Partner notification related attendance: Chlamydia contact |
| PNG | Partner notification related attendance: Gonorrhoea contact |
| PNH | Partner notification related attendance: HIV contact |
| PNN | Partner notification related attendance: Non-specific genital infection contact |
| PNP | Partner notification related attendance: PID/Epididymitis contact |
| PNS | Partner notification related attendance: Syphilis contact |
| PNT | Partner notification related attendance: Trichomoniasis contact |
| PR1 | Pregnant 1-12 weeks |
| PR2 | Pregnant 13-28 weeks |
| PR3 | Pregnant 29-40 weeks |
| PEPS | Post exposure prophylaxis after sexual exposure (PEPSE) |
| D3 |
Other Sexual Health and HIV Episodes not requiring treatment |
| O11-O99 | Research/New/Urgent reporting (Retired 01 October 2018) |
| 40 | Sexual Assault (Acute presentation) |
| 41 | Sexual Assault (Non - acute presentation) |
| CSE1 | Child sexual exploitation : concerns raised at internal assessment |
| CSE2 | Child sexual exploitation : concerns raised with internal safeguarding professionals |
| CSE3 | Child sexual exploitation : referred to external safeguarding professionals |
| DV | Concern of domestic violence (or abuse) |
| FGM | Female genital mutilation (of any type) |
| Z | Prisoner |
| SW | Sex Worker |
| R | Rectal infection |
| O | Pharyngeal infection |
| X | Previously diagnosed elsewhere |
| M | Medication given |
| Q | Quadrivalent HPV vaccine |
| A1X | Primary syphilis - previously diagnosed elsewhere |
| A2X | Secondary syphilis - previously diagnosed elsewhere |
| A3X | Early latent syphilis - previously diagnosed elsewhere |
| A4X | Cardiovascular syphilis - previously diagnosed elsewhere |
| A5X | Neurosyphillis syphilis - previously diagnosed elsewhere |
| A6X | All other late and latent syphilis - previously diagnosed elsewhere |
| A7AX | Congenital syphilis - previously diagnosed elsewhere |
| BR | Gonorrhoea - rectal infection |
| BO | Gonorrhoea - pharayngeal infection |
| BX | Gonorrhoea - previously diagnosed elsewhere |
| BM | Gonorrhoea - medication given |
| BRX | Gonorrhoea - rectal infection, previously diagnosed elsewhere |
| BRM | Gonorrhoea - rectal infection, medication given |
| BOX | Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere |
| BOM | Gonorrhoea - pharayngeal infection, medication given |
| C4R | Chlamydia - rectal infection |
| C4O | Chlamydia - pharayngeal infection |
| C4X | Chlamydia - previously diagnosed elsewhere |
| C4M | Chlamydia - medication given |
| C4RX | Chlamydia - rectal infection, previously diagnosed elsewhere |
| C4RM | Chlamydia - rectal infection, medication given |
| C4OX | Chlamydia - rectal infection, previously diagnosed elsewhere |
| C4OM | Chlamydia - pharayngeal infection, medication given |
| C2R | Lymphogranuloma venereum (LGV) - Rectal infection |
| C2O | Lymphogranuloma venereum (LGV) - Pharayngeal infection |
| C4NR | Non-specific genital infection (NSGI) - rectal infection (proctitis) |
| C6AX | Trichomoniasis - previously diagnosed elsewhere |
| H1X | New HIV diagnosis - previously diagnosed elsewhere |
| H1AX | New HIV diagnosis: acute - previously diagnosed elsewhere |
| H1BX | New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere |
| C10AM | Anogenital Herpes simplex: first episode - medication given |
| C10BM | Anogenital Herpes simplex: recurrent episode - medication given |
| C11AM | Anogenital warts infection: first episode - medication given |
| C11DM | Anogenital warts infection: recurrent episode - medication given |
| W1Q | HPV Vaccination: 1st dose - quadrivalent vaccine |
| W2Q | HPV Vaccination: 2nd dose - quadrivalent vaccine |
| W3Q | HPV Vaccination: 3rd dose - quadrivalent vaccine |
Also Known As
This attribute is also known by these names:
| Context | Alias |
|---|---|
| Formerly | GENITOURINARY EPISODE TYPE |
| Plural | SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES |
Where Used
| Type | Link | How used |
|---|---|---|
| Class | ACTIVITY PROPERTY | has an attribute SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE of type SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
| Attribute | ACTIVITY PROPERTY TYPE | references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
| Attribute | PRISONER INDICATOR | references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
| Attribute | SEX WORKER INDICATOR | references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
| Data Element | SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE | is the data element of SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
